Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody

Seetharama S. Konduru, Chien Tei Too, Kaval Kaur, Adam J. Gehring, Lionel Low, Alia Javiad, Teresa Pollicino, Li Li, Patrick T F Kennedy, Uri Lopatin, Paul A. Macary, Antonio Bertoletti

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Virus-specific CD8 T cells are activated when their T-cell receptors (TCRs) recognize the specific viral peptide/major histocompatibility complex (MHC) class I (pMHC) complexes present on the surface of infected cells. Antibodies able to recognize the specific pMHC can mimic TCR specificity and both represent a valuable biological tool to visualize pMHC complexes on infected cells and serve as a delivery system for highly targeted therapies. To evaluate these possibilities, we created a monoclonal antibody able to specifically recognize a hepatitis B virus (HBV) envelope epitope (Env at positions 183 to 91 [Env183-91]) presented by the HLA-A201 molecule, and we tested its ability to recognize HBV-infected hepatocytes and to deliver a cargo to a specific target. We demonstrate that this antibody detects and visualizes the processed product of HBV proteins produced in naturally HBV-infected cells, is not inhibited by soluble HBV proteins present in patient sera, and mediates the intracellular delivery of a fluorescent molecule to target cells. Additionally, compared to CD8 T cells specific for the same HBV epitope, the TCR-like antibody has both a superior sensitivity and a specificity focused on distinct amino acids within the epitope. These data demonstrate that a T-cell receptor-like antibody can be used to determine the quantitative relationship between HBV replication and specific antigen presentation to CD8 T cells and serves as a novel therapeutic delivery platform for personalized health care for HBV-infected patients.

Original languageEnglish
Pages (from-to)1935-1942
Number of pages8
JournalJournal of Virology
Volume85
Issue number5
DOIs
Publication statusPublished - Mar 2011
Externally publishedYes

Fingerprint

T-Cell Antigen Receptor
Hepatitis B virus
Antibodies
Epitopes
T-Lymphocytes
T-Cell Antigen Receptor Specificity
Antigen Presentation
Virus Replication
Major Histocompatibility Complex
Hepatocytes
Proteins
Monoclonal Antibodies
Viruses
Delivery of Health Care
Amino Acids
Sensitivity and Specificity
Peptides
Therapeutics
Serum

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Konduru, S. S., Too, C. T., Kaur, K., Gehring, A. J., Low, L., Javiad, A., ... Bertoletti, A. (2011). Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody. Journal of Virology, 85(5), 1935-1942. https://doi.org/10.1128/JVI.01990-10

Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody. / Konduru, Seetharama S.; Too, Chien Tei; Kaur, Kaval; Gehring, Adam J.; Low, Lionel; Javiad, Alia; Pollicino, Teresa; Li, Li; Kennedy, Patrick T F; Lopatin, Uri; Macary, Paul A.; Bertoletti, Antonio.

In: Journal of Virology, Vol. 85, No. 5, 03.2011, p. 1935-1942.

Research output: Contribution to journalArticle

Konduru, SS, Too, CT, Kaur, K, Gehring, AJ, Low, L, Javiad, A, Pollicino, T, Li, L, Kennedy, PTF, Lopatin, U, Macary, PA & Bertoletti, A 2011, 'Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody', Journal of Virology, vol. 85, no. 5, pp. 1935-1942. https://doi.org/10.1128/JVI.01990-10
Konduru, Seetharama S. ; Too, Chien Tei ; Kaur, Kaval ; Gehring, Adam J. ; Low, Lionel ; Javiad, Alia ; Pollicino, Teresa ; Li, Li ; Kennedy, Patrick T F ; Lopatin, Uri ; Macary, Paul A. ; Bertoletti, Antonio. / Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody. In: Journal of Virology. 2011 ; Vol. 85, No. 5. pp. 1935-1942.
@article{573577690d5049a4b809876133a47de2,
title = "Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody",
abstract = "Virus-specific CD8 T cells are activated when their T-cell receptors (TCRs) recognize the specific viral peptide/major histocompatibility complex (MHC) class I (pMHC) complexes present on the surface of infected cells. Antibodies able to recognize the specific pMHC can mimic TCR specificity and both represent a valuable biological tool to visualize pMHC complexes on infected cells and serve as a delivery system for highly targeted therapies. To evaluate these possibilities, we created a monoclonal antibody able to specifically recognize a hepatitis B virus (HBV) envelope epitope (Env at positions 183 to 91 [Env183-91]) presented by the HLA-A201 molecule, and we tested its ability to recognize HBV-infected hepatocytes and to deliver a cargo to a specific target. We demonstrate that this antibody detects and visualizes the processed product of HBV proteins produced in naturally HBV-infected cells, is not inhibited by soluble HBV proteins present in patient sera, and mediates the intracellular delivery of a fluorescent molecule to target cells. Additionally, compared to CD8 T cells specific for the same HBV epitope, the TCR-like antibody has both a superior sensitivity and a specificity focused on distinct amino acids within the epitope. These data demonstrate that a T-cell receptor-like antibody can be used to determine the quantitative relationship between HBV replication and specific antigen presentation to CD8 T cells and serves as a novel therapeutic delivery platform for personalized health care for HBV-infected patients.",
author = "Konduru, {Seetharama S.} and Too, {Chien Tei} and Kaval Kaur and Gehring, {Adam J.} and Lionel Low and Alia Javiad and Teresa Pollicino and Li Li and Kennedy, {Patrick T F} and Uri Lopatin and Macary, {Paul A.} and Antonio Bertoletti",
year = "2011",
month = "3",
doi = "10.1128/JVI.01990-10",
language = "English",
volume = "85",
pages = "1935--1942",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibody

AU - Konduru, Seetharama S.

AU - Too, Chien Tei

AU - Kaur, Kaval

AU - Gehring, Adam J.

AU - Low, Lionel

AU - Javiad, Alia

AU - Pollicino, Teresa

AU - Li, Li

AU - Kennedy, Patrick T F

AU - Lopatin, Uri

AU - Macary, Paul A.

AU - Bertoletti, Antonio

PY - 2011/3

Y1 - 2011/3

N2 - Virus-specific CD8 T cells are activated when their T-cell receptors (TCRs) recognize the specific viral peptide/major histocompatibility complex (MHC) class I (pMHC) complexes present on the surface of infected cells. Antibodies able to recognize the specific pMHC can mimic TCR specificity and both represent a valuable biological tool to visualize pMHC complexes on infected cells and serve as a delivery system for highly targeted therapies. To evaluate these possibilities, we created a monoclonal antibody able to specifically recognize a hepatitis B virus (HBV) envelope epitope (Env at positions 183 to 91 [Env183-91]) presented by the HLA-A201 molecule, and we tested its ability to recognize HBV-infected hepatocytes and to deliver a cargo to a specific target. We demonstrate that this antibody detects and visualizes the processed product of HBV proteins produced in naturally HBV-infected cells, is not inhibited by soluble HBV proteins present in patient sera, and mediates the intracellular delivery of a fluorescent molecule to target cells. Additionally, compared to CD8 T cells specific for the same HBV epitope, the TCR-like antibody has both a superior sensitivity and a specificity focused on distinct amino acids within the epitope. These data demonstrate that a T-cell receptor-like antibody can be used to determine the quantitative relationship between HBV replication and specific antigen presentation to CD8 T cells and serves as a novel therapeutic delivery platform for personalized health care for HBV-infected patients.

AB - Virus-specific CD8 T cells are activated when their T-cell receptors (TCRs) recognize the specific viral peptide/major histocompatibility complex (MHC) class I (pMHC) complexes present on the surface of infected cells. Antibodies able to recognize the specific pMHC can mimic TCR specificity and both represent a valuable biological tool to visualize pMHC complexes on infected cells and serve as a delivery system for highly targeted therapies. To evaluate these possibilities, we created a monoclonal antibody able to specifically recognize a hepatitis B virus (HBV) envelope epitope (Env at positions 183 to 91 [Env183-91]) presented by the HLA-A201 molecule, and we tested its ability to recognize HBV-infected hepatocytes and to deliver a cargo to a specific target. We demonstrate that this antibody detects and visualizes the processed product of HBV proteins produced in naturally HBV-infected cells, is not inhibited by soluble HBV proteins present in patient sera, and mediates the intracellular delivery of a fluorescent molecule to target cells. Additionally, compared to CD8 T cells specific for the same HBV epitope, the TCR-like antibody has both a superior sensitivity and a specificity focused on distinct amino acids within the epitope. These data demonstrate that a T-cell receptor-like antibody can be used to determine the quantitative relationship between HBV replication and specific antigen presentation to CD8 T cells and serves as a novel therapeutic delivery platform for personalized health care for HBV-infected patients.

UR - http://www.scopus.com/inward/record.url?scp=79551697736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551697736&partnerID=8YFLogxK

U2 - 10.1128/JVI.01990-10

DO - 10.1128/JVI.01990-10

M3 - Article

C2 - 21159876

AN - SCOPUS:79551697736

VL - 85

SP - 1935

EP - 1942

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 5

ER -